Skip to main content

Table 1 Relationship between CELF2 expression levels and clinicopathological parameters in 80 pancreatic cancer patients

From: N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer

Variables

All cases

CELF2 expression

P

Low (n = 48)

High (n = 32)

Age (years)

 <50

43

22

21

0.082

 ≥50

37

26

11

 

Gender

 Male

51

32

19

0.506

 Female

29

16

13

 

Alcohol history

 No

64

38

26

0.819

 Yes

16

10

6

 

Smoking

 No

28

17

11

0.894

 Yes

52

30

22

 

CEA

 Normal

 

16

9

0.622

 High

 

32

23

 

CA199

 Normal

 

13

11

0.486

 High

 

35

21

 

Tumor size (cm)

 <4

38

18

20

0.028*

 ≥4

42

30

12

 

TNM stage

 I–II

35

16

19

0.02

 III–IV

45

32

13

 

Lymph node invasion

 Absent

36

17

19

0.035*

 Present

44

31

13

 

Metastasis

 No

63

34

29

0.034

 Yes

17

14

3

 
  1. *P < 0.05.